Your browser doesn't support javascript.
loading
Timing the initiation of multiple myeloma.
Rustad, Even H; Yellapantula, Venkata; Leongamornlert, Daniel; Bolli, Niccolò; Ledergor, Guy; Nadeu, Ferran; Angelopoulos, Nicos; Dawson, Kevin J; Mitchell, Thomas J; Osborne, Robert J; Ziccheddu, Bachisio; Carniti, Cristiana; Montefusco, Vittorio; Corradini, Paolo; Anderson, Kenneth C; Moreau, Philippe; Papaemmanuil, Elli; Alexandrov, Ludmil B; Puente, Xose S; Campo, Elias; Siebert, Reiner; Avet-Loiseau, Herve; Landgren, Ola; Munshi, Nikhil; Campbell, Peter J; Maura, Francesco.
Affiliation
  • Rustad EH; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Yellapantula V; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Leongamornlert D; The Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, Cambridgeshire, CB10 1SA, UK.
  • Bolli N; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Ledergor G; Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Nadeu F; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, CA, USA.
  • Angelopoulos N; Patologia Molecular de Neoplàsies Limfoides, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036, Barcelona, Spain.
  • Dawson KJ; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029, Madrid, Spain.
  • Mitchell TJ; The Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, Cambridgeshire, CB10 1SA, UK.
  • Osborne RJ; The Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, Cambridgeshire, CB10 1SA, UK.
  • Ziccheddu B; The Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, Cambridgeshire, CB10 1SA, UK.
  • Carniti C; The Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, Cambridgeshire, CB10 1SA, UK.
  • Montefusco V; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Corradini P; Department of Molecular Biotechnologies and Health Sciences, University of Turin, Turin, Italy.
  • Anderson KC; Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Moreau P; Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Papaemmanuil E; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Alexandrov LB; Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Puente XS; Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Campo E; CRCINA, SIRIC ILIAD, University Hospital of Nantes, Nantes, France.
  • Siebert R; Computational Oncology Service, Department of Epidemiology & Biostatistics, Center for Computational Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Avet-Loiseau H; Department of Cellular and Molecular Medicine and Department of Bioengineering and Moores Cancer Center, University of California, La Jolla, San Diego, CA, USA.
  • Landgren O; Unitat Hematopatologia, Hospital Clínic of Barcelona, Universitat de Barcelona, 08036, Barcelona, Spain.
  • Munshi N; Departamento de Bioquimica y Biologia Molecular, Instituto Universitario de Oncologia (IUOPA), Universidad de Oviedo, Oviedo, Spain.
  • Campbell PJ; Patologia Molecular de Neoplàsies Limfoides, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036, Barcelona, Spain.
  • Maura F; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029, Madrid, Spain.
Nat Commun ; 11(1): 1917, 2020 04 21.
Article in En | MEDLINE | ID: mdl-32317634

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gene Expression Regulation, Neoplastic / Multiple Myeloma Type of study: Diagnostic_studies / Prognostic_studies / Screening_studies Limits: Humans Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2020 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gene Expression Regulation, Neoplastic / Multiple Myeloma Type of study: Diagnostic_studies / Prognostic_studies / Screening_studies Limits: Humans Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2020 Document type: Article Affiliation country: